Dario Maggioni

About

Dario Maggioni is a leading figure in minimally invasive surgical oncology, with a primary focus on gastric cancer treatment. His work has been instrumental in demonstrating the feasibility and long-term benefits of laparoscopic and robot-assisted gastrectomy for distal adenocarcinoma. Maggioni’s landmark 2010 study, with 139 citations, provided crucial evidence that subtotal gastrectomy with D2 lymph node dissection performed via minimally invasive surgery achieves excellent 5-year survival outcomes, challenging traditional open-surgery benchmarks. His earlier 2008 analysis of 65 patients, cited 67 times, systematically compared conventional laparoscopic and robot-assisted approaches, establishing safety and oncologic equivalence. Maggioni also contributed to adrenal surgery, reporting on 68 laparoscopic adrenalectomies. As a pioneer in robotic gastrectomy, his initial series of 17 patients helped validate the technology’s role in complex D2 dissections. Through these contributions, Maggioni has shaped modern surgical practice, proving that advanced minimally invasive techniques can match or surpass open surgery in oncologic efficacy while reducing patient morbidity.

Research Focus

Key Achievements

Top Papers

1. 1
   Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival

   139 citations · 2010
2. 2
   Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures

   67 citations · 2008
3. 3
   Outcomes of laparoscopic adrenalectomy. Clinical experience with 68 patients

   20 citations · 2007
4. 4
   Robot-assisted laparoscopic gastrectomy with D2 dissection for adenocarcinoma: initial experience with 17 patients

   11 citations · 2008

Key Collaborators

Contact & Links